Flow Cytometry Research Facility (FCRF) In 2014 the Flow Cytometry Research Facility (FCRF), formerly the Cell Analysis Facility, was re-branded to more accurately reflect the services offered. The FCRF is located in the Durham Research Center at the University of Nebraska Medical Center (UNMC) campus. The goal of the FCRF is to provide access to the latest instrumentation, leading scientific and technical expertise, with comprehensive flow cytometry support to all investigators at the University of Nebraska and the surrounding area. The facility houses two multicolor cell sorters with 14 simultaneous fluorescent parameter capabilities, one of which is contained within a class 2A biological safety cabinet. There are three analog analysis instruments with exceptional low-end resolution, ideal for DNA synthesis measurements. There are two high-end, multi-laser and multi-parameter flow cytometers with 14 and 18 simultaneous fluorescent parameters respectively. Both of these instruments are equipped with a high-throughput system for automation of 96-well plate analysis. Additionally, the facility has a pioneering high content, 9-laser, 30-parameter Fortessa X50 flow cytometer; with access to a suite of novel reagents and custom fluorochrome conjugations, the FCRF is in a position to offer world-leading, high-content flow cytometry capabilities to investigators at University of Nebraska. With the University of Nebraska currently investing and actively expanding its research infrastructure, the FCRF will become increasingly valuable to a growing research base over the coming five years. In the past 12 months there has been a strategic shift in operations at the FCRF, initiating a culture change in how researchers access flow cytometry services. This has given the FCRF the operational structure in place to support an increase in volume of use at the facility in the coming years and an increase in high-content flow cytometry applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA036727-33
Application #
9755219
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
33
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Schopfer, Lawrence M; Lockridge, Oksana (2018) Chlorpyrifos oxon promotes tubulin aggregation via isopeptide cross-linking between diethoxyphospho-Lys and Glu or Asp: Implications for neurotoxicity. J Biol Chem 293:13566-13577
Neilsen, Beth K; Chakraborty, Binita; McCall, Jamie L et al. (2018) WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage. BMC Cancer 18:673
Khadge, Saraswoti; Sharp, John Graham; Thiele, Geoffrey M et al. (2018) Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology. J Nutr Biochem 52:92-102
Baranovskiy, Andrey G; Duong, Vincent N; Babayeva, Nigar D et al. (2018) Activity and fidelity of human DNA polymerase ? depend on primer structure. J Biol Chem 293:6824-6843
Ingersoll, Matthew A; Chou, Yu-Wei; Lin, Jamie S et al. (2018) p66Shc regulates migration of castration-resistant prostate cancer cells. Cell Signal 46:1-14
Kuss, Mitchell; Kim, Jiyoung; Qi, Dianjun et al. (2018) Effects of tunable, 3D-bioprinted hydrogels on human brown adipocyte behavior and metabolic function. Acta Biomater 71:486-495
Ambardekar, Vishakha V; Wakaskar, Rajesh R; Ye, Zhen et al. (2018) Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration. Int J Pharm 543:130-138
Svechkarev, Denis; Kyrychenko, Alexander; Payne, William M et al. (2018) Development of colloidally stable carbazole-based fluorescent nanoaggregates. J Photochem Photobiol A Chem 352:55-64
Saxena, Sugandha; Purohit, Abhilasha; Varney, Michelle L et al. (2018) Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells. BMC Cancer 18:1283
Tian, Tian; Bi, Chengfeng; Hein, Ashley L et al. (2018) Rac1 is a novel therapeutic target in mantle cell lymphoma. Blood Cancer J 8:17

Showing the most recent 10 out of 1372 publications